Alkalmas-e a vizelet neutrofil gelatináz asszociálta lipokalin meghatározása a rejekció előrejelzésére veseátültetés után?

Introduction: Delayed graft function and acute rejection have negative impact on graft survival. Aim: To asses the predictive value of urinary neutrophil gelatinase-associated lipocalin, which has been found to be a promising biomarker for the diagnosis of acute kidney injury. Method: In this prospective study urinary neutrophil gelatinase-associated lipocalin levels of 27 kidney recipients were measured. Results: Patients were grouped as follows: group 1, no complication; group 2, rejection; group 3, delayed graft function requiring dialysis; group 4, rejection plus delayed graft function. There were no significant differences between groups 1 and 2, and between groups 3 and 4. Patients in groups 3 and 4 had significantly higher urinary neutrophil gelatinase-associated lipocalin levels as compared to those in groups 3 and 4. There was a paralIel change in urinary neutrophil gelatinase-associated lipocalin levels in groups 1 and 2. Conclusions: In these patients urinary neutrophil gelatinase-associated lipocalin levels failed to provide useful information in both cases of normal and impaired function. Orv. Hetil., 2015, 156(48), 1956–1959.